Systems Pharmacology and Toxicology Training Program
系统药理学和毒理学培训计划
基本信息
- 批准号:9063078
- 负责人:
- 金额:$ 13.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-07-01 至 2018-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Over the past few decades, our knowledge of the mechanisms by which cells interact with drugs and toxins has exploded due to new molecular analysis techniques and the application of genomic methods. Accordingly, the emphasis of graduate education in the disciplines of pharmacology and toxicology needs to shift from a reductionist view to a systems approach in which doctoral students are comprehensively trained so they can formulate a strategy to solve important biological questions not only at the molecular, cellular, and tissue levels but also at the whole-animal level. Systems pharmacology and toxicology describes a field of study that considers the broad view of drug action. A systems approach using in vivo animal models is necessary to establish efficacy, safety and the pharmacodynamic/pharmacokinetic profile of candidate drugs but there is a shortage of students trained in this area. Researchers trained in in vivo pharmacological and toxicological approaches to assess and interpret therapeutic potential are and will remain in high demand. This Systems Pharmacology and Toxicology (SPaT) Program is designed for PhD students pursuing dissertation research projects in the pharmacological sciences. Trainees (2/year for up to 2 years of support) and training faculty (28 mentors and 4 teachers) will be drawn from three PhD programs: Pharmacology, Interdisciplinary Toxicology and Interdisciplinary Biomedical Sciences. The SPaT program will train students to use an in vivo approach to answering relevant questions in pharmacology and toxicology with emphasis on metabolism, drug design, pharmacodynamics, pharmacokinetics, and signaling. The rationale for SPaT is that this type of training provides students with a much broader perspective on pharmacology and toxicology that better prepares them to be leaders of multi-disciplinary research teams in the pharmacological sciences. We will integrate SPaT into PhD training programs already active at our graduate training sites in the Little Rock area that include faculty/scientists in the Collegesof Medicine (COM), Pharmacy (COP), and Public Health (COPH) on the UAMS, the Arkansas Children's Hospital campus (ACH), and at the Food and Drug Administration (FDA)- funded National Center for Toxicological Research (NCTR). The unique focus of SPaT is training with in vivo systems pharmacological and toxicological approaches and concepts. The objective of SPaT is to provide in vivo pharmacology and toxicology training that complement the cellular and molecular training that students receive in their home programs. The training program consists of didactic training in pharmacology, toxicology, physiology, pharmacokinetics, metabolism, biostatistics, grant writing, and the responsible conduct of research (RCR) along with laboratory research using an in vivo model of human disease. The SPaT program will also provide strong mentoring, extensive networking, and teaching and leadership opportunities for its trainees through its programmatic activities.
描述(由申请人提供):在过去的几十年里,由于新的分子分析技术和基因组方法的应用,我们对细胞与药物和毒素相互作用机制的了解已经爆炸。因此,药理学和毒理学学科的研究生教育的重点需要从还原论的观点转向系统的方法,在这种方法中,博士生得到全面的培训,以便他们能够制定一种策略,不仅在分子,细胞和组织水平上解决重要的生物学问题,而且在整个动物水平上。系统药理学和毒理学描述了一个研究领域,认为药物作用的广泛观点。使用体内动物模型的系统方法对于确定候选药物的有效性、安全性和药效学/药代动力学特征是必要的,但在这一领域受过培训的学生短缺。研究人员在体内药理学和毒理学方法培训,以评估和解释治疗潜力是,并将继续在高需求。这个系统药理学和毒理学(SPaT)计划是专为博士生追求在药理学科学论文研究项目。受训人员(2/年,最多支持2年)和培训教师(28名导师和4名教师)将来自三个博士课程:药理学,跨学科毒理学和跨学科生物医学科学。SPaT计划将训练学生使用体内方法来回答药理学和毒理学中的相关问题,重点是代谢,药物设计,药效学,药代动力学和信号。SPaT的基本原理是,这种类型的培训为学生提供了更广泛的药理学和毒理学视角,使他们更好地准备成为药理学多学科研究团队的领导者。我们将SPaT整合到博士培训计划已经活跃在我们的研究生培训地点在小石城地区,包括教师/科学家在医学院(COM),药房(COP),公共卫生(COPH)的UAMS,阿肯色州儿童医院校园(ACH),并在食品和药物管理局(FDA)资助的国家毒理学研究中心(NCTR)。SPaT的独特重点是体内系统药理学和毒理学方法和概念的培训。SPaT的目标是提供体内药理学和毒理学培训,补充学生在家庭课程中接受的细胞和分子培训。培训计划包括药理学、毒理学、生理学、药代动力学、代谢、生物统计学、资助撰写和负责任的研究行为(RCR)沿着使用人体疾病体内模型的实验室研究的教学培训。SPaT计划还将通过其计划活动为其学员提供强有力的指导,广泛的网络,教学和领导机会。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Philip R. Mayeux其他文献
Renal Mitochondrial Dysfunction: Unraveling the Mystery of Sepsis Induced Renal Injury
- DOI:
10.1016/j.freeradbiomed.2011.10.120 - 发表时间:
2011-11-01 - 期刊:
- 影响因子:
- 作者:
Naeem K Patil;Nirmala Parajuli;Philip R. Mayeux;Lee Ann MacMillan-Crow - 通讯作者:
Lee Ann MacMillan-Crow
Receptor-mediated increase in cytosolic calcium in LLC-PK<sub>1</sub> cells by platelet activating factor and thromboxane A<sub>2</sub>
- DOI:
10.1038/ki.1991.317 - 发表时间:
1991-12-01 - 期刊:
- 影响因子:
- 作者:
Norishi Ueda;Philip R. Mayeux;Patrick D. Walker;Sudhir V. Shah - 通讯作者:
Sudhir V. Shah
RETRACTED ARTICLE: Sepsis-induced elevation in plasma serotonin facilitates endothelial hyperpermeability
撤回文章:脓毒症诱导的血浆血清素升高促进内皮高通透性
- DOI:
10.1038/srep22747 - 发表时间:
2016-03-09 - 期刊:
- 影响因子:3.900
- 作者:
Yicong Li;Coedy Hadden;Anthonya Cooper;Asli Ahmed;Hong Wu;Vladimir V. Lupashin;Philip R. Mayeux;Fusun Kilic - 通讯作者:
Fusun Kilic
Philip R. Mayeux的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Philip R. Mayeux', 18)}}的其他基金
Systems Pharmacology and Toxicology Training Program
系统药理学和毒理学培训计划
- 批准号:
8878304 - 财政年份:2013
- 资助金额:
$ 13.88万 - 项目类别:
Systems Pharmacology and Toxicology Training Program
系统药理学和毒理学培训计划
- 批准号:
8690116 - 财政年份:2013
- 资助金额:
$ 13.88万 - 项目类别:
Systems Pharmacology and Toxicology Training Program
系统药理学和毒理学培训计划
- 批准号:
8550926 - 财政年份:2013
- 资助金额:
$ 13.88万 - 项目类别:
Mechanistic targets for intervention in sepsis-induced renal injury
干预脓毒症肾损伤的机制目标
- 批准号:
7987557 - 财政年份:2009
- 资助金额:
$ 13.88万 - 项目类别:
Mechanistic targets for intervention in sepsis-induced renal injury
干预脓毒症肾损伤的机制目标
- 批准号:
8075010 - 财政年份:2008
- 资助金额:
$ 13.88万 - 项目类别:
Mechanistic targets for intervention in sepsis-induced renal injury
干预脓毒症肾损伤的机制目标
- 批准号:
7666223 - 财政年份:2008
- 资助金额:
$ 13.88万 - 项目类别:
Mechanistic targets for intervention in sepsis-induced renal injury
干预脓毒症肾损伤的机制目标
- 批准号:
8289664 - 财政年份:2008
- 资助金额:
$ 13.88万 - 项目类别:
MECHANISMS OF LIPID A TOXICITY IN RENAL PROXIMAL TUBULES
脂质A对肾近端小管的毒性机制
- 批准号:
2749477 - 财政年份:1991
- 资助金额:
$ 13.88万 - 项目类别:
CALCIUM AND ENDOTOXIN-INDUCED TUBULE CELL INJURY
钙和内毒素引起的肾小管细胞损伤
- 批准号:
2143986 - 财政年份:1991
- 资助金额:
$ 13.88万 - 项目类别:
MECHANISMS OF LIPID A TOXICITY IN RENAL PROXIMAL TUBULES
脂质A对肾近端小管的毒性机制
- 批准号:
6176488 - 财政年份:1991
- 资助金额:
$ 13.88万 - 项目类别:
相似国自然基金
基于铁死亡探讨黄芪甲苷调控System/Xc-/GSH/GPX4信号通路在神经损伤性勃起功能障碍治疗中的作用及机制研究
- 批准号:
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
Data-driven Recommendation System Construction of an Online Medical Platform Based on the Fusion of Information
- 批准号:
- 批准年份:2024
- 资助金额:万元
- 项目类别:外国青年学者研究基金项目
TBX1/LKB1轴阻断system Xc活性调控AML细胞铁死亡的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:15.0 万元
- 项目类别:省市级项目
TET2通过调控BAP1-System Xc-轴促进紫拉非尼诱导的肝细胞癌铁死亡的机制研究
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:青年科学基金项目
P3H1通过ATF4/System Xc-轴抑制肾癌铁死亡和抗肿瘤免疫反应的作用及机制研究
- 批准号:82372704
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于PNO1介导system Xc-/GSH途径调控肠上皮细胞自噬依赖性铁死亡探讨加味胶七散治疗溃疡性结肠炎的机制
- 批准号:82304982
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于单细胞测序探讨淫羊藿苷对Erastin诱导髓核细胞铁死亡相关system-Xc/GSH/GPX4分子轴线的调控作用
- 批准号:82360947
- 批准年份:2023
- 资助金额:33 万元
- 项目类别:地区科学基金项目
内皮细胞机械敏感离子通道Piezo1通过HIF-1α/system Xc-介导BBB破坏在急性脑缺血再灌注损伤中的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
miR-198 靶向 Nrf2 抑制 System Xc-通路调控滋养细胞铁死亡在子痫前期中的机制
- 批准号:2022JJ70123
- 批准年份:2022
- 资助金额:0.0 万元
- 项目类别:省市级项目
BAP1介导H2B去泛素化抑制System Xc-在蛛网膜下腔出血神经元铁死亡中的作用和机制研究
- 批准号:
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
NSFGEO-NERC: Imaging the magma storage region and hydrothermal system of an active arc volcano
NSFGEO-NERC:对活弧火山的岩浆储存区域和热液系统进行成像
- 批准号:
NE/X000656/1 - 财政年份:2025
- 资助金额:
$ 13.88万 - 项目类别:
Research Grant
System for 3D femtosecond laser-based micromachining
基于飞秒激光的 3D 微加工系统
- 批准号:
537273289 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Major Research Instrumentation
High-power Ytterbium femtosecond laser amplifier system
高功率镱飞秒激光放大器系统
- 批准号:
532577495 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Major Research Instrumentation
LC-MS/MS system with high-resolution mass spectrometer and nano-UHPLC - 2/2
配备高分辨率质谱仪和纳米 UHPLC 的 LC-MS/MS 系统 - 2/2
- 批准号:
527318363 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Major Research Instrumentation
An innovative urinary drainage system that could reduce NHS CAUTI treatment costs by 10% and increase quality-of-life for men suffering from chronic incontinence
%20创新%20泌尿%20引流%20系统%20%20可以%20减少%20NHS%20CAUTI%20治疗%20成本%20by%2010%%20和%20增加%20生活质量%20为%20男性%20痛苦%20来自%20慢性%20失禁
- 批准号:
10094849 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Collaborative R&D
SpyTCR-RBNP - Engineering a highly targeted and biocompatible drug delivery system for solid cancer treatment
SpyTCR-RBNP - 设计用于实体癌症治疗的高度针对性和生物相容性的药物输送系统
- 批准号:
10095606 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Collaborative R&D
HoloSurge: Multimodal 3D Holographic tool and real-time Guidance System with point-of-care diagnostics for surgical planning and interventions on liver and pancreatic cancers
HoloSurge:多模态 3D 全息工具和实时指导系统,具有护理点诊断功能,可用于肝癌和胰腺癌的手术规划和干预
- 批准号:
10103131 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
EU-Funded
INTEPS - INtegrated optical ThErmal Phosphorescence System
INTEPS - 集成光学热磷光系统
- 批准号:
10089333 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Collaborative R&D
Home Office Criminal Justice System Strategy Analysis Fellowship
内政部刑事司法系统战略分析奖学金
- 批准号:
ES/Y004906/1 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Fellowship
Trust in forensic science evidence in the criminal justice system: The experience of marginalised groups
刑事司法系统中对法医科学证据的信任:边缘群体的经历
- 批准号:
ES/Y010639/1 - 财政年份:2024
- 资助金额:
$ 13.88万 - 项目类别:
Research Grant